Mechanistically, Axl is a downstream target of yes-associated protein 1 (YAP1), frizzled-2 (FZD2), STAT3, and nuclear serine/threonine kinases NUAK1/2 in HCC [60,61] (Figure 2A). Here, AXL is linked to hepatocellular carcinoma.